GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quest PharmaTech Inc (TSXV:QPT) » Definitions » Cyclically Adjusted FCF per Share

Quest PharmaTech (TSXV:QPT) Cyclically Adjusted FCF per Share : C$0.00 (As of Oct. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Quest PharmaTech Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Quest PharmaTech's adjusted free cash flow per share for the three months ended in Oct. 2023 was C$0.000. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is C$0.00 for the trailing ten years ended in Oct. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Quest PharmaTech was 26.30% per year. The lowest was -14.50% per year. And the median was 12.60% per year.

As of today (2024-06-04), Quest PharmaTech's current stock price is C$0.02. Quest PharmaTech's Cyclically Adjusted FCF per Share for the quarter that ended in Oct. 2023 was C$0.00. Quest PharmaTech's Cyclically Adjusted Price-to-FCF of today is .


Quest PharmaTech Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Quest PharmaTech's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest PharmaTech Cyclically Adjusted FCF per Share Chart

Quest PharmaTech Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.02 -0.03 -0.03 - -0.03

Quest PharmaTech Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.03 - -0.03 -

Competitive Comparison of Quest PharmaTech's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Quest PharmaTech's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quest PharmaTech's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quest PharmaTech's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Quest PharmaTech's Cyclically Adjusted Price-to-FCF falls into.



Quest PharmaTech Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Quest PharmaTech's adjusted Free Cash Flow per Share data for the three months ended in Oct. 2023 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Oct. 2023 (Change)*Current CPI (Oct. 2023)
=-0/125.3095*125.3095
=0.000

Current CPI (Oct. 2023) = 125.3095.

Quest PharmaTech Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201401 -0.005 97.261 -0.006
201404 -0.007 98.920 -0.009
201407 -0.005 99.315 -0.006
201410 -0.003 99.473 -0.004
201501 -0.004 98.209 -0.005
201504 -0.003 99.710 -0.004
201507 -0.006 100.579 -0.007
201510 -0.002 100.500 -0.002
201601 -0.008 100.184 -0.010
201604 -0.011 101.370 -0.014
201607 -0.003 101.844 -0.004
201610 -0.008 102.002 -0.010
201701 -0.007 102.318 -0.009
201704 -0.007 103.029 -0.009
201707 -0.014 103.029 -0.017
201710 -0.004 103.424 -0.005
201801 -0.022 104.056 -0.026
201804 -0.007 105.320 -0.008
201807 -0.014 106.110 -0.017
201810 -0.007 105.952 -0.008
201901 -0.014 105.557 -0.017
201904 -0.010 107.453 -0.012
201907 -0.012 108.243 -0.014
201910 -0.010 107.927 -0.012
202001 -0.006 108.085 -0.007
202004 -0.013 107.216 -0.015
202007 -0.001 108.401 -0.001
202010 -0.001 108.638 -0.001
202101 0.012 109.192 0.014
202104 0.000 110.851 0.000
202107 -0.001 112.431 -0.001
202110 0.000 113.695 0.000
202201 0.000 114.801 0.000
202204 0.000 118.357 0.000
202207 -0.001 120.964 -0.001
202210 0.000 121.517 0.000
202301 -0.001 121.596 -0.001
202304 0.000 123.571 0.000
202307 -0.001 124.914 -0.001
202310 0.000 125.310 0.000

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Quest PharmaTech  (TSXV:QPT) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Quest PharmaTech Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Quest PharmaTech's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest PharmaTech (TSXV:QPT) Business Description

Industry
Traded in Other Exchanges
N/A
Address
8123 Roper Road NW, Edmonton, AB, CAN, T6E 6S4
Quest PharmaTech Inc is a Canadian-based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at the University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.
Executives
Ragupathy Madiyalakan Director

Quest PharmaTech (TSXV:QPT) Headlines

No Headlines